Browsing publications by Dr Sarah Fordham

Newcastle AuthorsTitleYearFull text
Dr Sarah Fordham
Mike Cole
Dr Julie Irving
Dr James Allan
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia2015
Dr Mark Wade
Dr Nicola Sunter
Dr Sarah Fordham
Anna Long
Dino Masic
et al.
c-MYC is a radiosensitive locus in human breast cells2014
Dr Sarah Fordham
Mike Cole
Dr Julie Irving
Dr James Allan
Cytarabine leaves a mutational fingerprint in relapsing leukemia2014
Dr Mohammad Moad
Dr Deepali Pal
Dr Anastasia Hepburn
Dr Stuart Williamson
Laura Wilson
et al.
A novel model of urinary tract differentiation, tissue regeneration, and disease: Reprogramming human prostate and bladder cells into induced pluripotent stem cells2013
Dr Sarah Fordham
Dr Helen Marr
Dr James Allan
Searching for clarity in therapy-related myelodysplastic syndrome/acute myeloid leukemia prognostication2013
Dr Sarah Fordham
Dr Victoria Forster
Professor Graham Jackson
Dr Simon Bomken
Dr James Allan
et al.
A functional variant in the core promoter of the CD95 cell death receptor gene predicts prognosis in acute promyelocytic leukemia2012
Dr Sarah Fordham
Professor Keith Scott
Dr Julie Irving
Dr James Allan
Cellular Response to Cytarabine is Modulated by the DNA Mismatch Repair Pathway: Implications for Treatment of Acute Myeloid Leukemia2010
Dr John Anderson
Dr Stephen Crosier
Lynne Overman
Dr Tryfonia Mainou-Fowler
Dr Sarah Fordham
et al.
Survivin in diffuse large B cell lymphoma: Evaluation as a prognostic marker2005